Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00249
|
|||||
Drug Name |
Cannabidiol
|
|||||
Synonyms |
(-)-CBD; (-)-Cannabidiol; (-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol; (-)-trans-Cannabidiol; 19GBJ60SN5; CBD; Epidiolex; GWP42003-P; QHMBSVQNZZTUGM-ZWKOTPCHSA-N; UNII-19GBJ60SN5; delta1(2)-trans-Cannabidiol
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Lennox-Gastaut syndrome [ICD11: 8A62.1] | Approved | [1] | |||
Dravet syndrome [ICD11: 8A61.11] | Approved | [1] | ||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C21H30O2
|
|||||
Canonical SMILES |
CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O
|
|||||
InChI |
InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1
|
|||||
InChIKey |
QHMBSVQNZZTUGM-ZWKOTPCHSA-N
|
|||||
CAS Number |
CAS 145514-04-1
|
|||||
Pharmaceutical Properties | Molecular Weight | 314.5 | Topological Polar Surface Area | 40.5 | ||
Heavy Atom Count | 23 | Rotatable Bond Count | 6 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 2 | |||
XLogP |
6.5
|
|||||
PubChem CID | ||||||
PubChem SID |
103460177
, 104014242
, 104152845
, 109827355
, 113635231
, 12012585
, 134990571
, 135697550
, 136213730
, 142472550
, 14825860
, 14899058
, 160711726
, 162224688
, 178100971
, 198983043
, 224092533
, 226491388
, 242059005
, 24892861
, 250138861
, 252159978
, 252415453
, 43765781
, 57309735
, 57408178
, 57654032
, 80649036
, 841235
, 8707245
|
|||||
ChEBI ID |
CHEBI:69478
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Cannabidiol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01665) |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.